VERO
Venus Concept Inc.
$0.31
+0.01 (+2.64%)
At close · Apr 6
Market Cap
$578,187
Shares
1,859,123
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.31
Open$0.31
Day$0.27–0.38
52W$0.25–14.50
Avg vol 30d19K
Short int13K · 0.7% float · 1.0d
Short vol4%
Last earningsNov 13, 2025
DataJan 2020–Apr 2026
Filing10-Q · Nov 13
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Nov 13, 2025
Equibles Rating
blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Poor
Quant / Vol
Very High
Market backdrop
VIX 15 · calm
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−83%
below
Price vs 50-day avg
−47%
below
RSI (14)
42
neutral
MACD trend
Positive
52-week position
0%
near low
Momentum
relative strength
1-month return
−20%
trailing
6-month return
−87%
trailing
YTD return
−79%
this year
Relative strength
−88%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Distributing
-10% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.72% of float · ▼ -5.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
9 holders — near 1-yr low, contrarian setup
Fundamentals
Revenue growth
−15%
Y/Y
Gross margin
68%
expanding
EPS growth
−4%
Y/Y
Free cash flow
$-11.2M
Balance sheet
$31.9M
net debt
Quant / Vol
risk profile
Volatility
526%
annualized · 1-yr
Max drawdown
−97%
past year
ATR
40.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−83%
Bearish
Price vs 50-day avg
−47%
Bearish
RSI (14)
42
Neutral
MACD trend
Positive
Bullish
52-week position
0%
Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Distributing
-10% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.72% of float · ▼ -5.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
9 holders — near 1-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $0
Now $0 · 0%
52-wk high $15
vs 200-day avg -83%
vs 50-day avg -47%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
VERO
this stock
Venus Concept Inc.
|
$578,187 | -79.0% | -15.1% | — | 0.7% |
|
ABT
Abbott Laboratories
|
$163.61B | -24.7% | +5.7% | 26.3 | 1.3% |
|
SYK
Stryker Corp
|
$126.42B | -5.9% | +11.2% | 38.2 | 1.8% |
|
MDT
Medtronic plc
|
$107.36B | -12.0% | +8.4% | 22.5 | 1.5% |
|
BSX
Boston Scientific Corp
|
$66.54B | -53.0% | +5.5% | 18.7 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| VERO | -7.7% | -20.3% | -86.8% | -11.9% | -79.0% |
| SPY | +3.9% | -2.0% | +0.9% | +1.3% | -3.4% |
| vs SPY | -11.6% | -18.3% | -87.7% | -13.2% | -75.6% |